Small Cap Bulls
No Result
View All Result
  • Login
  • Home
  • Biotech
  • Crypto
  • Energy
  • Mining
  • Tech
  • Opinion
  • Home
  • Biotech
  • Crypto
  • Energy
  • Mining
  • Tech
  • Opinion
No Result
View All Result
Small Cap Bulls
No Result
View All Result
Home Biotech

Psychotropics in Canada: Looking Ahead

Jordan Pike by Jordan Pike
November 18, 2024
Reading Time: 6 mins read
0
Psychotropics in Canada: Looking Ahead

As outlined in a recent article, if psychedelics, psychotropics or any combination of the substance were to be legalized in Canada, it would likely occur in three different waves. The first is decriminalization, as weโ€™ve seen in a variety of US Cities and countries, then medical access (similar to how Cannabis medicalization occurred), and finally total legalization, in the way we currently have Cannabis legalized in Canada.ย 

RELATED POSTS

Neuropsychiatry: The Definitive 2025 Analysis of Investment & Scientific Breakthroughs

Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures

Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights

Focusing on the first wave, decriminalization, I was intrigued of the current state of this matter in Canada. As previously stated, there is an e-petition set to be presented at the House of Commons this fall.ย 

I recently spoke with both Paul Manly, MP for Nanaimo-Ladysmith, BC whoโ€™s sponsoring the petition, and Trevor Millar, a social entrepreneur and activist largely involved with the creation of the petition.ย 

For me, one area of the petition immediately presented a fury of questions. The petition statesย  โ€œAmend the Controlled Drugs and Substances Act, the Food and Drug Act and regulations to distinguish and exempt these organisms when used for therapeutic practices, as adjuncts to medical care, for healing ceremonies or solitary spiritual growth and self-development.โ€ Yet, if individuals would then be able to cultivate these psychotropic substances for the designated purposes, wouldnโ€™t Canadians legally be able to grow these plants and then exploit them for recreational purposes?ย 

Manly and Millar interestingly presented different perspectives on my inquiry. Manly states that the vagueness of the language of the petition was deliberate for that reason โ€œI think when people talk about exploration. Is that recreation or is that personal exploration? I mean, thatโ€™s a great kind of a gray zone, I’d say.โ€ In contrast, Millar stated that โ€œTo be honest, recreationally, it is not the worst thing on earth. If I look at a schedule of all of the most dangerous drugs, David Nutt from the Imperial College in London, he put together a list of all the drugs that are the most dangerous, the most dangerous, by far is alcohol. The least dangerous, is magic mushrooms. If we’re going to allow people to use alcohol recreationally, which is incredibly dangerous, I think it’s fair to allow the plant to be used recreationally as wellโ€.ย 

Yet, both Millar and Manly state the dangers of ignorantly using these substances, such as Ibogaine.
โ€œIt’s not something you would use outside of a therapeutic situation or outside of, you know, working with somebody that really understands what they’re doingโ€ states Manly. Millar delved into the legality of the substance, which has consistently been proven to combat addiction. Prior to 2017, Ibogaine was legal in Canada for all purposes, and then in 2017, it was placed in the prescription list. Millar states โ€œBut on the prescription drug list, it still hasn’t gone through Phase One, Two and Three clinical trials. So it’s in this kind of regulatory no go zone.โ€ So, even though it can be used as a prescription legally in Canada, its research and trials are almost non-existent.ย 

Manly also clarified that if the government was to develop a Bill, Health Canada would be instrumental in establishing a proper public health framework and approach to psychotropics. He also notes how โ€œ the war on drugs is a colossal failure. It’s a massive waste of money.โ€ Another element of the petition that prompted him to sponsor was โ€œDoing this incremental approach of letting people who need these plant medicines, get access to them.โ€ Manly clearly sees it as fairly black and white – thereโ€™s people who require plant medicine, and they should be entitled to it.

He also sees the petition as a crucial step towards respecting and preserving the rituals of Indigenous Cultures in Canada โ€œwhat we need to do is actually respect those cultures and respect those traditions, and not be criminalizing those traditions, which is what the laws have doneโ€ states Manly. For Manly, while he is merely just the politician sponsoring the petition, the issue connected to him on a personal level.ย 

โ€œI had a cousin who had schizophrenia. He died of an opioid overdose in the back of a Greyhound bus after getting out of prison for the umpteenth time. I also lost a friend. He was murdered for a drug debt when I was in my early 20s.”

He also points to the War on Drugs in Canada and how this petition could potentially change that โ€œIn our country, we have a disproportionate number of people in our prison system who are racialized orIndigenous. And a lot of it has to do with the war on drugs and criminalizing the poor.โ€ He furthers by stating how, โ€œThe harm caused by the war on drugs far outweighs the benefits of whatever they were trying to do.โ€

Yet, despite the mountain of evidence that supports Ibogaine for addiction help, when Millarโ€™s Liberty Roots applied to use Ibogaine through the Special Access Drug Programme, they were denied,ย 

โ€œbecause unfortunately as far as the bureaucrats to Health Canada are concerned, there’s still not enough evidence to support the use of Ibogaine because there hasn’t been the Phase One, Two and Three clinical trials.โ€ Millar is tirelessly working on completing these trials in hopes that he can access the substance through the Special Access Drug Programme in the future. Millar plans to re-apply soon and go public with an Ibogaine treatment in Canada. He feels more optimistic this time around as โ€œI have some political support that indicates that if I do apply through the special access drug programme, I may get permission for it againโ€. While I previously have written about accessing illicit substances through the Section 56 exemption, it is crucial to note why Millar is using the Special Access Programme instead. This is because Ibogaine and Iboga are not considered illicit, but rather on the prescription list.ย 

Millar also spoke of the importance of a harm reduction approach to Psychotropics. Specifically, he believes in professional training in educating people on how to use psychedelics โ€œIf we can create a robust, you know, beautiful kind of heart centered way of training people how to use psychedelics, let’s do that.โ€ He highlights educational institutions that are spearheading this such as University of Ottawa and California Institute of Integrated Studies. For those interested in learning more on the matter, Millar notes that a virtual town hall will take place in July and all relevant information will be posted online.ย 

The final strategy that Millar is employing in an effort to illustrate the significance of Psychotropics to the Canadian Government is โ€œWe’re aiming to reach out to every member of parliament in Canada and have a conversation with them about plant medicines focusing on mushroomsโ€ฆ we’re looking for people in each riding, to reach out to that Member of Parliament that arrange a meeting. Millar states that if anyone is interested in reaching out to their MP about this matter, then to contact decriminalizenature.ca and they can help facilitate the exchange.ย 

Overall, it will be fascinating to observe how the petition plays out in Parliament in the Fall. As well, it will be worthwhile to observe whether Millar is finally granted access to Ibogaine through the Special Access Drug Programme, which would constitute an increasingly open-minded stance towards the substance by Health Canada and the Canadian Government. It is comforting to know that within the Canadian landscape of Psychotropics, both Manly and Millar emerge as two leading and passionate voices.ย 

Tags: canadadecriminlizationpetitionpsychotropics
ShareTweetPin
Jordan Pike

Jordan Pike

Related Posts

Neuro Psych
Biotech

Neuropsychiatry: The Definitive 2025 Analysis of Investment & Scientific Breakthroughs

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs
Biotech

Cybin Announces Financing of up to US$500 Million Aggregate Principal Amount of Convertible Debentures

Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs
Biotech

Cybin Reports Fiscal Year 2025 Financial Results and Recent Business Highlights

Unpacking Biotechโ€™s Future: Inside RTW Investmentsโ€™ Strategy with Roderick Wong
Biotech

Unpacking Biotechโ€™s Future: Inside RTW Investmentsโ€™ Strategy with Roderick Wong

Trump Top Priority
Biotech

Trump-Era Support Sparks Renewed Hope for Psychedelic Therapy in Treating PTSD and Depression

Cybinโ€™s Psychedelic Breakthrough: Why Investors Should Pay Attention to This Mental Health Game-Changer
Biotech

Cybinโ€™s Psychedelic Breakthrough: Why Investors Should Pay Attention to This Mental Health Game-Changer

Next Post
DIY Mycology, Magic Mushrooms in your Closet

DIY Mycology, Magic Mushrooms in your Closet

Psychedelic Therapy in a Post-COVID World: Why Itโ€™s More Crucial Than Ever

Psychedelic Therapy in a Post-COVID World: Why Itโ€™s More Crucial Than Ever

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

Recommended Stories

Bitcoin ASIC Production Expansion by Bitmain in the US

Bitcoin ASIC Production Expansion by Bitmain in the US

Fibonacci Retracements: Key to Market Analysis Strategy

Fibonacci Retracements: Key to Market Analysis Strategy

XRP Price Prediction: Must Stabilize Above $2.50 for Gains

XRP Price Prediction: Must Stabilize Above $2.50 for Gains

Popular Stories

  • Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024

    Cybin Inc: The Psychedelic Revolution in Mental Health Treatment is Here

    27 shares
    Share 0 Tweet 0
  • Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs

    0 shares
    Share 0 Tweet 0
  • Aeroplan Status Calculator

    0 shares
    Share 0 Tweet 0
  • BlackRock Bitcoin ETF Sees Rally: What’s Next for IBIT?

    0 shares
    Share 0 Tweet 0
  • Universal Digital Inc. (Formerly Minas Metals Ltd.) Announces Completion of Change of Business

    0 shares
    Share 0 Tweet 0
Small Cap Bulls

Small Cap Bulls is your trusted source for uncovering small-cap companies on the brink of explosive growth. With in-depth analysis and expert insights, we help investors navigate the dynamic world of small-cap stocks. Join us as we charge ahead, empowering your investment journey.

2024 Small Cap Bulls – Charging Ahead. All Rights Reserved.

By using this site you agree to the Terms of Use, Privacy Policy, and Service Agreement.

Navigate

  • Uncategorized
  • Tech
  • Policy
  • Opinion
  • Mining
  • Medical & Wellness
  • Health
  • Energy
  • Crypto
  • Business & Finance
  • Biotech

stay connected

Join our newsletter

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Biotech
  • Energy
  • Mining
  • Health
  • Crypto
  • Tech
  • Terms of Use

© 2024 Small Cap Bulls - Charging Ahead. All Rights Reserved. By using this site you agree to the Terms of Use, Privacy Policy, and Service Agreement.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?